Lenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS)

Affiliation auteursAffiliation ok
TitreLenalidomide (LEN) Maintenance Following High-Dose Melphalan and Autologous Stem Cell Transplant (ASCT) in Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): A Meta-Analysis of Overall Survival (OS)
Type de publicationJournal Article
Year of Publication2017
AuteursMcCarthy P, Holstein S, Petrucci MTeresa, Richardson P, Hulin C, Tosi P, Bringhen S, Musto P, Anderson KC, Caillot D, Gay F, Moreau P, Marit G, Jung S-H, Yu Z, Winograd B, Knight R
JournalCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Volume17
PaginationE6
Date PublishedFEB
Type of ArticleMeeting Abstract
ISSN2152-2650
DOI10.1016/j.clml.2017.03.011